MARKET

GILD

GILD

Gilead Sciences Inc
NASDAQ
168.08
+0.13
+0.08%
Pre Market: 170.40 +2.32 +1.38% 07:38 11/16 EST
OPEN
168.58
PREV CLOSE
167.95
HIGH
169.12
LOW
166.94
VOLUME
1.72K
TURNOVER
--
52 WEEK HIGH
176.58
52 WEEK LOW
114.31
MARKET CAP
208.48B
P/E (TTM)
-53.4045
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GILD last week (1109-1113)?
Weekly Report · 4h ago
Barclays Reaffirms Their Hold Rating on Gilead Sciences (GILD)
TipRanks · 4h ago
SA Asks: What are the most attractive Big Pharma stocks right now?
Seeking Alpha · 17h ago
Gilead Beat the S&P 500 by More Than 25 Points in the Past Year, but $1,000 From a Decade Ago Is Still Worth Less Than $3,500
24/7 Wall St. · 22h ago
Gilead Sciences (GILD) Wins Bixlenvo Approval With Another FDA Call Due In December
Simply Wall St · 1d ago
Gilead Sciences Earnings Call Signals Broad Growth Momentum
TipRanks · 1d ago
Moderna Inc. Stock Slips 3.4%, Underperforms Peers
Dow Jones · 2d ago
Evercore ISI cuts Legend Biotech to In Line ahead of ‘meaningful headwinds’
TipRanks · 2d ago
More
About GILD
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer, and inflammation. It is focused on discovering, developing, and delivering medicines to address unmet medical needs in virology, oncology, and other therapeutic areas. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Livdelzi/Lyvdelzi, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, and others. It also sells and distributes authorized generic versions of Epclusa and Harvoni in the United States through its subsidiary, Asegua Therapeutics LLC. It has control on anitocabtagene autoleucel (anito cel), an investigational BCMA-directed CAR T cell therapy for multiple myeloma. The Company also owns an antibody-drug conjugates (ADCs) platform.

Webull offers Gilead Sciences, Inc stock information, including NASDAQ: GILD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GILD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GILD stock methods without spending real money on the virtual paper trading platform.